Evidence map›Paper›PMID 33277284›Full record

ArticleBMJ open2020

Study protocol: treatment with caffeine of the very preterm infant in the delivery room: a feasibility study.

Carlo Dani, Alessandra Cecchi, Giulia Remaschi, Domenica Mercadante, Giancarlo la Marca, Luca Boni, Fabio Mosca

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04044976 (Treatment With Caffeine of Very Preterm Infant in the Delivery Room), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04044976 nacompletednot on this map

Treatment With Caffeine of Very Preterm Infant in the Delivery Room: the CAFROOM Feasibility Study

TypeinterventionalSponsorUniversity of FlorenceRan2019 to 2021Enrolled42ConditionsRespiratory Distress SyndromeArmsCaffeine Citrate
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Indications and timings for caffeine initiation in preterm infants.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Carlo DaniDepartment of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Firenze, Italy cdani@unifi.it.ORCID 0000-0002-1639-621X
Alessandra CecchiDivision of Neonatology, Careggi University Hospital of Florence, Florence, Italy.
Giulia RemaschiDivision of Neonatology, Careggi University Hospital of Florence, Florence, Italy.
Domenica MercadanteFondazione IRCCS Cà Granda Ospedale Maggiore Policlinico of Milan, University of Milan, Florence, Italy.
Giancarlo la MarcaLaboratory of Clinical Chemistry and Pharmacology of the A Meyer Pediatric Hospital of Florence, University of Florence, Florence, Italy.
Luca BoniDepartment of Human Pathology and Oncology, University of Florence, Florence, Italy.
Fabio MoscaDepartment of Clinical Sciences and Community Health, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
Azienda Ospedaliero-Universitaria Careggi · ITUniversity of Florence · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITMeyer Children's Hospital · ILUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEarly treatment with caffeine in the delivery room has been proposed to decrease the need for mechanical ventilation (MV) by limiting episodes of apnoea and improving respiratory mechanics in preterm infants. Thus, the purpose of this feasibility study is to verify the hypothesis that intravenous or enteral administration of caffeine can be performed in the preterm infant in the delivery room. METHODS AND ANALYSIS: In this multicentre prospective study, infants with 25 ETHICS AND DISSEMINATION: The study has been approved by the Italian Medicines Agency (AIFA: AIFA/RSC/P/32755) and by Comitato Etico Pediatrico Regione Toscana. The results will be published in peer-reviewed academic journals. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov identifier NCT04044976; EudraCT number 2018-003626-91.

Indexed as

Delivery RoomsCaffeineFeasibility StudiesFemaleHumansInfantInfant, NewbornInfant, PrematureItalyMulticenter Studies as TopicPregnancyProspective StudiesRandomized Controlled Trials as TopicCaffeineneonatologyperinatologyrespiratory medicine (see thoracic medicine)

Identifiers

PMID33277284
PMCPMC7722383
OpenAlexW3110477697

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.